GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1126 - 1150 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G71142DF
805
IgG Patient 2 3 mild
G71142DF
159
IgM Patient 2 3 mild
G71142DF
1537
IgA Patient 3 -180 mild
G71142DF
497
IgA Patient 3 11 mild
G71142DF
1432
IgG Patient 3 -180 mild
G71142DF
124
IgM Patient 3 -180 mild
G71142DF
737
IgA Patient 3 4 mild
G71142DF
1152
IgG Patient 3 11 mild
G71142DF
395
IgG Patient 3 4 mild
G71142DF
300
IgM Patient 3 11 mild
G71142DF
3903
IgM Patient 3 4 mild
G71142DF
3025
IgA Patient 4 12 mild
G71142DF
1037
IgG Patient 4 12 mild
G71142DF
331
IgM Patient 4 12 mild
G71142DF
1944
IgA Patient 1 10 moderate
G69912LP
361
IgA Patient 1 22 moderate
G69912LP
340
IgA Patient 1 6 moderate
G69912LP
282
IgG Patient 1 10 moderate
G69912LP
23
IgG Patient 1 22 moderate
G69912LP
25
IgM Patient 1 10 moderate
G69912LP
35
IgM Patient 1 22 moderate
G69912LP
78
IgG Patient 1 6 moderate
G69912LP
23
IgM Patient 1 6 moderate
G69912LP
33
IgA Patient 2 15 mild
G69912LP
664

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024